CLINICAL_TRIALS
trial_result
· 2018-04-26
Clinical Trial Update: A Study of LY2127399 in Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 study of Eli Lilly's LY2127399 in rheumatoid arthritis was terminated, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2018-04-26